Docebo's Buyback Gambit: Debt, Doubt, and a Shareholder's Twist

TORONTO – February 18, 2026 – Learning technology provider Docebo Inc. is navigating a complex financial maneuver, launching a US$60 million share buyback that is now intertwined with the shifting intentions of its majority shareholder and a significant new reliance on debt. The move, which the company frames as a response to an undervalued stock price, has been met with market skepticism, creating a stark contrast between internal confidence and external uncertainty.

In an update to its previously announced substantial issuer bid, the AI-powered learning platform confirmed it is proceeding with its offer to repurchase a large block of its common shares. However, the dynamics of the buyback have been reshaped by a pivotal change: Intercap Equity Inc., Docebo's dominant shareholder, has reversed its earlier stance and may now participate in the offer.

A Complex Capital Maneuver

Docebo is offering to repurchase up to US$60 million of its outstanding common shares for US$20.40 per share. The company’s board of directors maintains its support for the offer, stating its belief that “the current trading price of the Common Shares is not fully reflective of the value of the Company’s business and future prospects.” By repurchasing shares, a company can increase its earnings per share and signal to the market that it believes its own stock is the best available investment.

To fund this significant expenditure, Docebo will draw approximately US$30 million from its cash reserves and take on US$30 million in new debt. This marks a strategic shift for the company, which, as of late 2025, was noted for its debt-free balance sheet. The new debt will be drawn from a recently amended and expanded credit facility, which has been doubled from US$50 million to US$100 million. This expanded facility, secured against the company's assets, provides not only the funds for the buyback but also future flexibility for acquisitions and other corporate purposes.

While taking on debt increases financial risk, the move also equips Docebo with enhanced capital flexibility. The company projects strong performance for the upcoming fiscal year, with expected revenues between $267.5 million and $269.5 million, suggesting it is confident in its ability to service the new debt while continuing to invest in its growth initiatives.

The Intercap Enigma

The most significant wrinkle in Docebo’s plan is the revised intention of Intercap Equity Inc. The investment firm, which beneficially owns approximately 56.6% of Docebo’s shares, initially stated it would not participate in the buyback. Such a move would have naturally increased its ownership percentage as the total number of outstanding shares decreased.

However, Intercap has now informed Docebo that it may tender shares into the offer, with the stated goal of maintaining its current ownership level. The decision is attributed to “Intercap’s internal capital management considerations.” This complex relationship is underscored by the fact that Jason Chapnik serves as Chairman of Docebo's board while also being the Chairman and CEO of Intercap.

“Intercap’s change of intention relates solely to Intercap’s capital management requirements and should not be interpreted as a view on Docebo’s value or prospects,” Mr. Chapnik stated in the press release. “As Docebo’s largest shareholder, Intercap remains committed to the Company and believes strongly in its future… Our goal is to manage our capital needs appropriately while maintaining the largest stake possible in Docebo.”

This move suggests Intercap may be seeking liquidity from its large Docebo position without unsettling the market or significantly altering its control. The firm has actively managed its stake in the past, including selling a block of shares for substantial proceeds in 2021 when the stock price was significantly higher.

Market Skepticism Meets Analyst Optimism

Despite the board’s vote of confidence, the market’s reaction has been tepid. Following the latest update, Docebo’s stock on the Toronto Stock Exchange (TSX: DCBO) touched a new 52-week low. Shares have frequently traded below US$19.00 since the initial bid was announced, a notable discount to the US$20.40 offer price, indicating a degree of investor doubt about the offer’s attractiveness or the company's near-term valuation.

This market sentiment is in direct opposition to the views of many financial analysts. Wall Street consensus remains largely positive, with a dozen analysts covering the stock offering an average 12-month price target of over US$33.00, representing a potential upside of more than 75% from recent trading levels. Analysts see the issuer bid as a prudent use of capital that should unlock shareholder value, viewing the current stock price as a disconnect from the company's strong fundamentals and growth prospects in the corporate learning space.

Balancing Innovation and Financial Engineering

For a company that built its reputation on being an AI-driven innovator in the enterprise software market, the recent focus on financial engineering presents a strategic crossroads. The share buyback and assumption of debt are classic moves of a more mature company aiming to optimize its capital structure and deliver direct returns to shareholders, sometimes at the expense of aggressive growth investment.

Yet, Docebo appears determined to do both. The company’s own financial forecasts point to continued double-digit revenue and adjusted EBITDA growth. The newly expanded US$100 million credit facility, with an accordion feature for a further US$50 million, is explicitly available for general corporate purposes and acquisitions. This suggests that the buyback is not an endpoint for investment but rather one part of a broader capital allocation strategy designed to leverage a depressed share price while retaining the financial firepower for strategic growth.

As the offer’s expiration date of March 10, 2026, approaches, shareholders are left to weigh these conflicting signals. They must decide whether to accept the certain premium offered by the company or to bet alongside management and analysts on a long-term recovery that reflects the fundamental value Docebo insists the market is currently overlooking.